Skip to main content



Dr. Hiral Parekh is board-certified in Internal Medicine, Hematology, and Medical Oncology, and practices at our Northside location. Originally from India, Dr. Parekh received her medical degree from Govt Medical College in Surat, India. After receiving her Masters of Public Health from the East Tennessee State University, she completed a residency and two fellowships at the University of Oklahoma and Cleveland Clinic, respectively.

“The field of hematology and oncology is exciting and challenging, at the same time”, Dr. Parekh says. “The emotional turmoil that cancer diagnosis creates in someone’s life is impossible to describe… but the feeling of being able to help someone facing the biggest challenge of their life is very fulfilling”.  She strives to be available to her patients 24/7 “as a physician and as a friend”.

Believing in the importance of helping patients understand their diagnosis, she creates a road map for their treatment plan and strives to empower them with a wealth of information. “As their physicians, I want to provide them with full support for the obstacles that they face emotionally, socially, and physically”, she says. She felt that Cancer Specialists’ mission to holistic cancer treatment aligned perfectly with her goal to support her patients in all ways they need.

Dr. Parekh considers each of her patients like family: “I take honor in taking care of my patients and I consider that it is my responsibility to hold their hand, walk with them during their journey, and provide them with full support”.

When not at work, Dr. Parekh enjoys traveling, cooking, sketching and painting, and seeing the world through the eyes of her young daughters.

Curriculum Vitae


Medical Oncology
Internal Medicine


American Society of Clinical Oncology
Florida Society of Clinical Oncology
NRG Oncology


University of Oklahoma Health Sciences Center
Cleveland Clinic, Taussig Cancer Institute
Experimental Therapeutics


University of Oklahoma Health Sciences Center
Internal Medicine


Govt Medical College
East Tennessee State University
Master of Public Health


Journal Of The National Cancer Institute
Immunotherapy for Colorectal Cancer: A Review of Current and Novel Therapeutic Approaches
Clinical Genitourinary Cancer
Active Smoking Is Associated With Worse Prognosis in Metastatic Renal Cell Carcinoma Patients Treated With Targeted Therapies
Gynecologic Oncology Reports
Extragastrointestinal Stromal Tumors of the Pelvic Cavity and the Vagina: Two Case Reports and Review of the Literature
Current Treatment Options in Oncology
The Multidisciplinary Approach to Localized Pancreatic Adenocarcinoma
Journal of Gastrointestinal Cancer
Clinical Factors as a Component of the Personalized Treatment Approach to Advanced Pancreatic Cancer: a Systematic Literature Review
Clinical Colorectal Cancer
Total Neoadjuvant Therapy: A Shifting Paradigm in Locally Advanced Rectal Cancer Management
Future Oncology
Rini B.Axitinib for the treatment of metastatic renal cell carcinoma
American Journal of Hematology
Bone marrow necrosis discovered in a patient with suspected thrombotic thrombocytopenic purpura.
Journal of Clinical Microbiology
Case Series fusariosis occurring in the setting of posaconazole prophylaxis
Journal of Clinical Oncology
Multiple Organ Dysfunction syndrome secondary to micro-metastatic Adenocarcinoma of prostate – A case report